{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:03:45Z","timestamp":1761919425858},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T00:00:00Z","timestamp":1302652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s13365-011-0027-4","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T15:30:21Z","timestamp":1302622221000},"page":"288-290","source":"Crossref","is-referenced-by-count":22,"title":["Natalizumab and HSV meningitis"],"prefix":"10.1007","volume":"17","author":[{"given":"Erica Seiguer","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio M.","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagagopal","family":"Venna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,13]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMe020157","volume":"348","author":"UH Andrian Von","year":"2003","unstructured":"Von Andrian UH, Engelhardt B (2003) \u03b14 Integrins as therapeutic agents in autoimmune disease. N Engl J Med 348:68\u201372","journal-title":"N Engl J Med"},{"key":"27_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller DH, Khan OA, Sheremata WA et al (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348:15\u201323","journal-title":"N Engl J Med"},{"key":"27_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","volume":"348","author":"S Ghosh","year":"2003","unstructured":"Ghosh S, Goldin E, Gordon FH et al (2003) Natalizumab for active Chron\u2019s disease. N Engl J Med 348:24\u201332","journal-title":"N Engl J Med"},{"key":"27_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G Assche Van","year":"2005","unstructured":"Van Assche G, Van Ranst M, Sciot R et al (2005) Progressive multifocal leukencephalopathy after natalizumab therapy for Crohn\u2019s disease. N Engl J Med 353:362\u2013368","journal-title":"N Engl J Med"},{"key":"27_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ et al (2005) Progressive multifocal leukencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375\u2013381","journal-title":"N Engl J Med"},{"key":"27_CR6","unstructured":"Scheiss N, Zong J, Hayward G, Calabresi P et al. (2009) Reactivation of herpes virus in multiple sclerosis patients on natalizumab therapy [P03.163]. Poster presentation, April 29, 2009 at the American Academy of Neurology"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05789.x","volume":"132","author":"KA Thursky","year":"2005","unstructured":"Thursky KA, Worth LJ, Seymour JF (2005a) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. Br J Haematol 132:3\u201312","journal-title":"Br J Haematol"},{"issue":"17","key":"27_CR8","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","volume":"359","author":"AJ Coles","year":"2008","unstructured":"CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 359(17):1786\u20131801","journal-title":"N Engl J Med"},{"key":"27_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05789.x","volume":"132","author":"KA Thursky","year":"2005","unstructured":"Thursky KA, Worth LJ, Seymour JF et al (2005b) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. Br J Haematol 132:3\u201312","journal-title":"Br J Haematol"},{"key":"27_CR10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archneur.65.5.596","volume":"65","author":"JR Berger","year":"2008","unstructured":"Berger JR, Houff S (2008) Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 65:596\u2013600","journal-title":"Arch Neurol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-011-0027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-011-0027-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-011-0027-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:50:26Z","timestamp":1560124226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-011-0027-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,13]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s13365-011-0027-4","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,13]]}}}